Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Teva’s Health Care Reform Campaign Emphasizes Cost Over Expanded Access

Executive Summary

Teva's "Year of Affordable Medicine" campaign is beginning, affordably enough, on YouTube

You may also be interested in...



Medicaid Reform: Teva Wants Payments To Encourage Generic Substitution

The overarching political priority for generic drug firms at the moment is creation of a pathway for follow-on biologics. But the industry also hopes that general healthcare reform efforts provide an opportunity to consolidate gains the sector has made around small molecule products as well

Medicaid Reform: Teva Wants Payments To Encourage Generic Substitution

The overarching political priority for generic drug firms at the moment is creation of a pathway for follow-on biologics. But the industry also hopes that general healthcare reform efforts provide an opportunity to consolidate gains the sector has made around small molecule products as well

Senate Follow-On Biologics Bill Still Stuck In Evergreen Forest

Despite moving a bill out of committee last session, the Senate is still wrangling over the issue of whether modifications of existing products should get full exclusivity.

Topics

UsernamePublicRestriction

Register

LL1126093

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel